Nearly 3 million Medicare Advantage members had to switch plans in 2026 after insurers withdrew coverage options. Rural beneficiaries faced the highest disruption rates, with some states seeing over 90% of enrollees forced to find new coverage. (Source: Reuters)
Key Takeaways
Source: Reuters
A new research letter in JAMA analyzes the impact of Medicare Advantage plan exits, finding that millions of enrollees are forced to select new coverage when insurers withdraw. The study notes that such disruptions can complicate care coordination, especially for seniors with complex medical needs, fueling debate over marketplace stability.
Federal regulators have ordered a temporary halt on new enrollments in certain Elevance Health Medicare Advantage plans after identifying compliance issues. The action reflects growing federal scrutiny of private insurers to ensure they meet program requirements and protect beneficiaries.
The U.S. Department of Justice has reached a settlement with Aetna over allegations that the insurer used inaccurate diagnostic coding to improperly increase Medicare Advantage payments. The case underscores federal efforts to ensure accurate reporting of patient health conditions for payment accuracy.
A proposed update to Medicare Advantage payment rules has generated a record number of public comments from insurers, providers, and advocacy groups. The proposal aims to refine insurer reimbursements and address concerns about the risk-score calculations used to determine payments.
Pharmaceutical company Eli Lilly recently warned that some Medicare drug plans may charge more than the expected $50 monthly cap for certain weight-loss medications. The issue highlights the complexity of how new drug pricing policies interact with Medicare prescription drug coverage. While reforms aim to reduce costs for seniors, experts say the rollout may vary depending on how insurers structure their formularies.
Rheumatologists welcomed provisions in a recently enacted US federal spending package that extended some telehealth coverage and may eventually lower drug prices, but they found mixed results in terms of direct federal support for arthritis programs. (Source: Medscape, Michigan State Medical Society)
President Trump Signs Arrington’s Groundbreaking Cancer Detection Bill Into Law
(Source: U.S. House of Representatives Press Release)